Background Atypical hemolytic uremic syndrome (aHUS) is characterized by
microangiopathic hemolytic anemia, thrombocytopenia and kidney injury caused by a …

Atypical hemolytic uremic syndrome (aHUS) is a rare renal disease (two per one million in
the USA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and …

Introduction: Atypical hemolytic uremic syndrome (aHUS) is a rare disorder characterized by
the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury …

Background Atypical haemolytic uremic syndrome (aHUS) is a rare but severe form of
thrombotic microangiopathy as a consequence of complement dysregulation. aHUS has a …

Introduction Eculizumab is effective treatment of pediatric atypical hemolytic uremic
syndrome (aHUS). However, the optimal duration of treatment is not clearly defined. The aim …

Síndrome Hemolítico Urêmica atípica (SHUa), isto é, não associada à Escherichia coli,
produtora de Shiga toxina, é vista em 5% a 10% dos casos de Síndrome Hemolítico …

Atypical hemolytic uremic syndrome (aHUS) is a genetic, life-threatening, chronic disease
that can affect patients of all ages. aHUS is caused by uncontrolled complement activation …

Primary atypical hemolytic-uremic syndrome is a rare disease characterized by non-immune
microangiopathic hemolytic anemia, thrombocytopenia, and renal dysfunction; it is related to …

Background Atypical hemolytic uremic syndrome (aHUS) is characterized by the triad of
microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. Neonatal …

Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease often related
to uncontrolled complement activation. The use of eculizumab has changed the …